MBD2 and neuroblastoma: Indeed, consistent with this, Yang et al. showed that treatment of MYC-positive neuroblastoma cells with ciclopirox, an antifungal agent that also acts as a pan-demethylase inhibitor, resulted in a reduction in NB cell viability [27].